Romosozumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年7月10日 · Romosozumab (brand name Evenity) is a sclerostin inhibitor that may be used to treat osteoporosis in women after menopause who are at high risk of fractures (broken bones), or who cannot use another osteoporosis medicine or other osteoporosis medicines did not work well. Romosozumab should not be used for more than 12 doses (12 months).
Romosozumab - StatPearls - NCBI Bookshelf
2024年7月19日 · Romosozumab is a humanized monoclonal antibody sclerostin inhibitor that is United States Food and Drug Administration (FDA)-approved to treat osteoporosis in postmenopausal women who are at an increased risk of fracture.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
2016年10月20日 · Romosozumab, a monoclonal antibody that binds sclerostin, increases bone formation and decreases bone resorption. We enrolled 7180 postmenopausal women who had a T score of –2.5 to –3.5 at...
A new therapy for osteoporosis: Romosozumab - Harvard Health
2019年7月17日 · Based on this research, a year of romosozumab therapy, followed by an anti-resorptive agent like alendronate, zoledronate, or denosumab, is a new and effective option for certain women to prevent fractures related to osteoporosis.
Evenity: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年9月25日 · Evenity (romosozumab) injection is a treatment for osteoporosis in postmenopausal women to help reduce the risk of bone fractures. Evenity injections help create new bone and slow down bone loss, increasing bone mineral density and reducing spine fracture risk.
Romosozumab or Alendronate for Fracture Prevention in …
2017年10月12日 · Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption.
Romosozumab-aqqg (subcutaneous route) - Mayo Clinic
2024年1月31日 · Romosozumab-aqqg injection is used to treat osteoporosis (thinning and weakening of the bones) in postmenopausal women who are at high risk of fracture (history of osteoporotic fracture) or have used another osteoporosis medicine that did not work well.
2016年9月18日 · Romosozumab, a monoclonal antibody that binds sclerostin, increases bone for-mation and decreases bone resorption. We enrolled 7180 postmenopausal women who had a T score of –2.5 to –3.5 at...
Treatment for Postmenopausal Osteoporosis | EVENITY® (romosozumab …
EVENITY is a one-of-a-kind osteoporosis treatment—the first and only one that works both ways by building new bone and slowing bone loss to a lesser degree. Ask your doctor if it’s time to start building new bone with EVENITY.
Romosozumab: Dosage, Mechanism/Onset of Action, Half-Life
2020年2月10日 · Includes Romosozumab indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.
- 某些结果已被删除